DirectMeds Expands Horizons with Autumn DNA Acquisition

Deal News | Jun 04, 2025 | Globenewswire

DirectMeds Expands Horizons with Autumn DNA Acquisition

DirectMeds, a prominent telehealth provider of weight loss treatments, has acquired Autumn DNA, a company specializing in personalized supplements based on genetic data. This acquisition signals DirectMeds' ambition to expand into holistic, precision-based wellness. Autumn DNA's proprietary algorithm can analyze over 500 health markers and produce billions of personalized vitamin combinations, allowing DirectMeds to offer comprehensive wellness solutions. The integration enables consumers to use DNA testing for personalized supplement plans, a significant advancement in outcome-focused virtual care. Both CEOs view this acquisition as a strategic alignment of their missions, focusing on making personalized wellness accessible. The acquisition aims to address the rising consumer demand for individualized care, especially for those using GLP-1-based treatments who experience side effects that might hinder their health progress.

Sectors

  • Telehealth & Healthcare Technology
  • Personalized Medicine & Genomics

Geography

  • United States – The article mentions SALT LAKE CITY, indicating the primary geographical focus of DirectMeds. Both companies are expanding services that cater to the U.S. market.

Industry

  • Telehealth & Healthcare Technology – The industry pertains to companies involved in providing virtual healthcare services, such as DirectMeds which offers telehealth consultations and prescription delivery.
  • Personalized Medicine & Genomics – This industry focuses on using genetic information for personalized treatment, which is central to Autumn DNA's services in providing DNA-based supplement plans.

Financials

    Participants

    NameRoleTypeDescription
    DirectMedsAcquirerCompanyA leader in telehealth-driven GLP-1 weight loss treatments aiming to provide comprehensive wellness solutions through virtual care.
    Autumn DNATarget CompanyCompanyA personalized supplement company utilizing genetic and lifestyle data to offer tailored nutrition solutions.
    Chris ArmstrongCEO of DirectMedsPersonCEO of DirectMeds, involved in leading the company's expansion and acquisition strategy.
    Gianni LotfiCEO and Co-founder of Autumn DNAPersonCEO and Co-founder of Autumn DNA, involved in integrating personalized wellness solutions with DirectMeds.